Sanmina Reports Second Quarter Fiscal 2021 Financial Results

PR Newswire

SAN JOSE, Calif., May 3, 2021 /PRNewswire/ — Sanmina Corporation (“Sanmina” or the “Company”) (NASDAQ: SANM), a leading integrated manufacturing solutions company, today reported financial results for the fiscal second quarter ended April 3, 2021 and outlook for its fiscal third quarter ending July 3, 2021.


Second Quarter Fiscal 2021 Financial Highlights

 •  Revenue: $1.7 billion, midpoint of outlook

 •  GAAP operating margin: 3.8 percent

 •  GAAP diluted EPS: $0.70

 •  Non-GAAP(1) operating margin: 5.0 percent

 •  Non-GAAP diluted EPS: $1.01, exceeded outlook


Additional Second Quarter Highlights

 •  Non-GAAP pre-tax ROIC: 27.6 percent

 •  Cash flow from operations: $81 million

 •  Free cash flow: $67 million  

 •  Ending cash and cash equivalents: $575 million


 (1)

Non-GAAP financial measures exclude charges or gains relating to: stock-based compensation expenses; restructuring costs (including employee severance and benefits costs and charges related to excess facilities and assets); acquisition and integration costs (consisting of costs associated with the acquisition and integration of acquired businesses into our operations); impairment charges for goodwill and other assets; amortization expense; and other unusual or infrequent items (e.g. charges or benefits associated with distressed customers, expenses, charges and recoveries relating to certain legal matters, gains and losses on sales of assets, deferred tax adjustments and discrete tax items). See Schedule 1 below for more information regarding our use of non-GAAP financial measures, including the economic substance behind each exclusion, the manner in which management uses non-GAAP measures to conduct and evaluate the business, the material limitations associated with using such measures and the manner in which management compensates for such limitations. A reconciliation of the non-GAAP financial information contained in this release to their most directly comparable GAAP measures is included in the financial statements furnished with this release.

“We achieved solid financial results for the second fiscal quarter, despite the challenges associated with supply chain constraints and the typical seasonality. This performance was driven by broad end-market demand, favorable mix and operational execution. I commend our employees for their commitment to deliver on our customers’ expectations,” stated Jure Sola, Chairman and Chief Executive Officer of Sanmina Corporation. 

“Our third quarter outlook reflects strong demand across our customer base while taking into account our current understanding of the supply constraints facing the industry and the COVID-19 pandemic. Our focus on fundamentals, coupled with the quality of our customer relationships, gives us confidence in the long-term financial prospects of our company.” 

Third Quarter Fiscal 2021 Outlook

The following outlook is for the third fiscal quarter ending July 3, 2021.  These statements are forward-looking and actual results may differ materially. 

  • Revenue between $1.675 billion to $1.775 billion
  • GAAP diluted earnings per share between $0.71 to $0.81
  • Non-GAAP diluted earnings per share between $0.84 to $0.94

The statements above concerning our expectations for customer demand during the third quarter and financial outlook constitute forward-looking statements within the meaning of the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934. Actual results could differ materially from those projected in these statements as a result of a number of factors, mostly notably the ongoing impacts of the COVID-19 pandemic, which have reduced demand from our customers, caused supply chain interruptions and created health risks for our employees and which could result in restrictions on where we can build products and our ability to fully staff our plants. Other factors that could cause our results to differ from our outlook include adverse changes to the key markets we target; significant uncertainties that can cause our future sales and net income to be variable; reliance on a small number of customers for a substantial portion of our sales; risks arising from our international operations; and the other factors set forth in the Company’s annual and quarterly reports filed with the Securities Exchange Commission (“SEC”).

The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter any of the forward-looking statements made in this earnings release, the conference call or the Investor Relations section of our website whether as a result of new information, future events or otherwise, unless otherwise required by law.

Company Conference Call Information

Sanmina will hold a conference call to review its financial results for the second quarter and outlook for the third quarter on Monday, May 3, 2021 at 5:00 p.m. ET (2:00 p.m. PT).  The access numbers are: domestic 866-891-4420 and international 201-383-2868. The conference will also be webcast live over the Internet.  You can log on to the live webcast at www.sanmina.com.  Additional information in the form of a slide presentation is available on Sanmina’s website at www.sanmina.com.  A replay of the conference call will be available for 48-hours.  The access numbers are: domestic 855-859-2056 and international 404-537-3406, access code is 4858475.

About Sanmina

Sanmina Corporation, a Fortune 500 company, is a leading integrated manufacturing solutions provider serving the fastest growing segments of the global Electronics Manufacturing Services (EMS) market. Recognized as a technology leader, Sanmina provides end-to-end manufacturing solutions, delivering superior quality and support to Original Equipment Manufacturers (OEMs) primarily in the communications networks, cloud solutions, industrial, defense, medical and automotive. Sanmina has facilities strategically located in key regions throughout the world. More information about the Company is available at www.sanmina.com.

 


Sanmina Corporation


Condensed Consolidated Balance Sheets


(in thousands)


(GAAP)

April 3,

October 3,

2021

2020

(Unaudited)


ASSETS

Current assets:

Cash and cash equivalents

$    575,176

$    480,526

Accounts receivable, net

1,122,962

1,043,334

Contract assets

334,957

396,583

Inventories

785,406

861,281

Prepaid expenses and other current assets

38,584

37,718

Total current assets

2,857,085

2,819,442

Property, plant and equipment, net

529,651

559,242

Deferred tax assets

259,943

273,470

Other

123,550

120,502

Total assets

$ 3,770,229

$ 3,772,656


LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$ 1,108,994

$ 1,210,049

Accrued liabilities 

176,148

171,761

Accrued payroll and related benefits

114,704

122,029

Short-term debt, including current portion of long-term debt

18,750

18,750

Total current liabilities

1,418,596

1,522,589

Long-term liabilities:

Long-term debt

320,405

329,249

Other

296,121

290,902

Total long-term liabilities

616,526

620,151

Stockholders’ equity

1,735,107

1,629,916

Total liabilities and stockholders’ equity

$ 3,770,229

$ 3,772,656

 


Sanmina Corporation


Condensed Consolidated Statements of Income


(in thousands, except per share amounts)


(GAAP)


(Unaudited)

Three Months Ended

Six Months Ended

April 3,

March 28,

April 3,

March 28,

2021

2020

2021

2020

Net sales

$ 1,699,677

$ 1,590,550

$ 3,454,926

$ 3,430,721

Cost of sales

1,556,579

1,483,129

3,170,593

3,188,418

Gross profit

143,098

107,421

284,333

242,303

Operating expenses:

Selling, general and administrative

61,142

62,257

120,109

125,408

Research and development

5,353

5,767

10,158

10,967

Restructuring and other costs 

11,880

15,028

13,784

24,378

     Total operating expenses

78,375

83,052

144,051

160,753

Operating income

64,723

24,369

140,282

81,550

Interest income

244

418

474

728

Interest expense 

(4,880)

(6,040)

(9,834)

(11,917)

Other income (expense), net

6,143

(7,660)

8,010

(6,342)

Interest and other, net

1,507

(13,282)

(1,350)

(17,531)

Income before income taxes

66,230

11,087

138,932

64,019

Provision for income taxes 

19,193

6,205

43,874

20,792

Net income

$      47,037

$        4,882

$      95,058

$      43,227

Basic income per share

$          0.72

$          0.07

$          1.46

$          0.61

Diluted income per share

$          0.70

$          0.07

$          1.42

$          0.60

Weighted-average shares used in computing per share amounts:

  Basic

65,249

70,584

65,244

70,377

  Diluted

66,957

72,245

66,887

72,429

 


Sanmina Corporation


Reconciliation of GAAP to Non-GAAP Measures


(in thousands, except per share amounts)


(Unaudited)

Three Months Ended

April 3,

Jan. 2,

March 28,

2021

2021

2020

GAAP Operating Income

$      64,723

$      75,559

$      24,369


GAAP operating margin


3.8%


4.3%


1.5%

Adjustments:

Stock compensation expense (1)

9,224

8,209

7,783

Amortization of intangible assets

63

Distressed customer charges (2)

(296)

(325)

Legal and other (3)

1,873

Restructuring costs

11,880

1,904

8,356

Goodwill and other asset impairments

6,609


Non-GAAP Operating Income


$      85,531


$      87,220


$      47,180



Non-GAAP operating margin



5.0%



5.0%



3.0%

GAAP Net Income

$      47,037

$      48,021

$        4,882

Adjustments:

Operating income adjustments (see above)

20,808

11,661

22,811

Legal and other (3)

(4,807)

(259)

Adjustments for taxes (4)

4,402

8,652

(4,655)


Non-GAAP Net Income


$      67,440


$      68,334


$      22,779


GAAP Net Income Per Share:


Basic


$          0.72


$          0.74


$          0.07


Diluted


$          0.70


$          0.72


$          0.07


Non-GAAP Net Income Per Share:


Basic


$          1.03


$          1.05


$          0.32


Diluted


$          1.01


$          1.02


$          0.32


Weighted-average shares used in computing per share amounts:


Basic


65,249


65,243


70,584


Diluted


66,957


66,818


72,245

(1)

Stock compensation expense was as follows: 

Cost of sales

$        3,629

$        3,421

$        2,582

Selling, general and administrative

5,479

4,718

5,127

Research and development

116

70

74

  Total

$        9,224

$        8,209

$        7,783

(2)

Relates to accounts receivable and inventory write-downs (recoveries) associated with distressed customers.

(3)

Represents expenses, charges and recoveries associated with certain legal matters.

(4)

GAAP provision for income taxes

$      19,193

$      24,681

$        6,205

Adjustments:

  Tax impact of operating income adjustments

284

280

222

  Discrete tax items

(232)

(6,451)

3,244

  Deferred tax adjustments

(4,454)

(2,481)

1,189

Subtotal – adjustments for taxes

(4,402)

(8,652)

4,655

Non-GAAP provision for income taxes

$      14,791

$      16,029

$      10,860


Q3 FY21 Earnings Per Share Outlook*:


Q3 FY21 EPS Range


Low


 High 

GAAP diluted earnings per share


$          0.71


$          0.81

  Stock compensation expense 


$          0.13


$          0.13

Non-GAAP diluted earnings per share


$          0.84


$          0.94

* Due to uncertainty regarding the timing of recognition of restructuring charges, impairment charges and other unusual or infrequent items, if any, that could be incurred during the third quarter of FY21, an estimate of such items is not included in the outlook for Q3 FY21 GAAP EPS.

 


Sanmina Corporation


Pre-Tax Return on Invested Capital (ROIC)


(in thousands)


(Unaudited)


 Q2 FY21 


Pre-tax Return on Invested Capital (ROIC)

GAAP operating income

$    64,723


 x 

4.0

Annualized GAAP operating income

258,892

Average invested capital (1)


 ÷ 

1,237,417


GAAP pre-tax ROIC


20.9%

Non-GAAP operating income

$    85,531


 x 

4.0

Annualized non-GAAP operating income

342,124

Average invested capital (1)


 ÷ 

1,237,417


Non-GAAP pre-tax ROIC


27.6%

(1) Invested capital is defined as total assets (not including cash and cash equivalents and deferred tax assets) less total liabilities (excluding short-term and long-term debt).

 


Sanmina Corporation


Condensed Consolidated Cash Flow Statement


(in thousands)


(Unaudited)

Three Month Periods

Q2’21

Q2’20

GAAP Net Income

$ 47,037

$     4,882

Depreciation and amortization

27,196

28,042

Other, net

19,498

16,029

Net change in net working capital

(12,642)

86,775

       Cash provided by operating activities

81,089

135,728

Net purchases of property & equipment

(14,349)

(16,410)

        Cash used in investing activities

(14,349)

(16,410)

Net share repurchases

(1,502)

(64,163)

Net borrowing activities

(4,688)

629,702

         Cash used in financing activities

(6,190)

565,539

Effect of exchange rate changes

(1,404)

(836)

Net change in cash & cash equivalents

$ 59,146

$ 684,021

Free cash flow:

   Cash provided by operating activities

$ 81,089

$ 135,728

   Net purchases of property & equipment

(14,349)

(16,410)

$ 66,740

$ 119,318


Schedule 1

The statements above and financial information provided in this earnings release include non-GAAP measures of operating income, operating margin, net income, diluted earnings per share and pre-tax return on invested capital (ROIC).  Management excludes from these measures stock-based compensation, restructuring, acquisition and integration expenses, impairment charges, amortization charges and other unusual or infrequent items, as adjusted for taxes, as more fully described below.

Management excludes these items principally because such charges or benefits are not directly related to the Company’s ongoing core business operations. We use such non-GAAP measures in order to (1) make more meaningful period-to-period comparisons of the Company’s operations, both internally and externally, (2) guide management in assessing the performance of the business, internally allocating resources and making decisions in furtherance of Company’s strategic plan, (3) provide investors with a better understanding of how management plans and measures the business and (4) provide investors with a better understanding of our ongoing, core business. The material limitations to management’s approach include the fact that the charges, benefits and expenses excluded are nonetheless charges, benefits and expenses required to be recognized under GAAP and, in some cases, consume cash which reduces the Company’s liquidity. Management compensates for these limitations primarily by reviewing GAAP results to obtain a complete picture of the Company’s performance and by including a reconciliation of non-GAAP results to GAAP results in its earnings releases.

Additional information regarding the economic substance of each exclusion, management’s use of the resultant non-GAAP measures, the material limitations of management’s approach and management’s methods for compensating for such limitations is provided below.

Stock-based Compensation Expense, which consists of non-cash charges for the estimated fair value of equity awards granted to employees and directors, is excluded in order to permit more meaningful period-to-period comparisons of the Company’s results since the Company grants different amounts and value of equity awards each quarter. In addition, given the fact that competitors grant different amounts and types of equity awards and may use different valuation assumptions, excluding stock-based compensation permits more accurate comparisons of the Company’s core results with those of its competitors.

Restructuring, Acquisition and Integration Expenses, which consist of severance, lease termination costs, exit costs and other charges primarily related to closing and consolidating manufacturing facilities and those associated with the acquisition and integration of acquired businesses, are excluded because such charges (1) can be driven by the timing of acquisitions and exit activities which are difficult to predict, (2) are not directly related to ongoing business results and (3) do not reflect expected future operating expenses. In addition, given the fact that the Company’s competitors complete acquisitions and adopt restructuring plans at different times and in different amounts than the Company, excluding these charges or benefits permits more accurate comparisons of the Company’s core results with those of its competitors. Items excluded by the Company may be different from those excluded by the Company’s competitors and restructuring and integration expenses include both cash and non-cash expenses. Cash expenses reduce the Company’s liquidity. Therefore, management also reviews GAAP results including these amounts.

Impairment Charges, which consist of non-cash charges, are excluded because such charges are non-recurring and do not reduce the Company’s liquidity. In addition, given the fact that the Company’s competitors may record impairment charges at different times, excluding these charges permits more accurate comparisons of the Company’s core results with those of its competitors.

Amortization Charges, which consist of non-cash charges impacted by the timing and magnitude of acquisitions of businesses or assets, are also excluded because such charges do not reduce the Company’s liquidity. In addition, such charges can be driven by the timing of acquisitions, which is difficult to predict. Excluding these charges permits more accurate comparisons of the Company’s core results with those of its competitors because the Company’s competitors complete acquisitions at different times and for different amounts than the Company.    

Other Unusual or Infrequent Items, such as  charges or benefits associated with distressed customers, expenses, charges and recoveries relating to certain legal matters, gains and losses on sales of assets, deferred tax adjustments and discrete tax items, are excluded because such items are typically non-recurring, difficult to predict or not directly related to the Company’s ongoing or core operations and are therefore not considered by management in assessing the current operating performance of the Company and forecasting earnings trends. However, items excluded by the Company may be different from those excluded by the Company’s competitors. In addition, these items may include both cash and non-cash expenses. Cash expenses reduce the Company’s liquidity. Management compensates for these limitations by reviewing GAAP results including these amounts.

Adjustments for Taxes, which consist of the tax effects of the various adjustments that we exclude from our non-GAAP measures, and adjustments related to deferred tax and discrete tax items.  Including these adjustments permits more accurate comparisons of the Company’s core results with those of its competitors. We determine the tax adjustments based upon the various applicable effective tax rates.  In those jurisdictions in which we do not expect to realize a tax cost or benefit (due to a history of operating losses or other factors), a reduced tax rate is applied.

Cision View original content:http://www.prnewswire.com/news-releases/sanmina-reports-second-quarter-fiscal-2021-financial-results-301282402.html

SOURCE Sanmina Corporation

Curaleaf Announces Upcoming Investor Community Conference and Event Participation

PR Newswire

WAKEFIELD, Mass., May 3, 2021 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced that Executive Chairman Boris Jordan and Chief Executive Officer Joe Bayern will be participating in the following investor community conferences and events during May 2021.

  • A.G.P.’s Spring Virtual Consumer Cannabis Conference

    May 4, 2021

    Joe Bayern, Curaleaf CEO, will be participating in a panel titled, “Northeast Opportunities:  Evaluating New Adult-use Markets of New York & New Jersey” hosted by Alliance Global Partners Equity Analyst Aaron Grey CFA, CPA. (12:00pm1:00pm) Curaleaf management will also be hosting investor one-on-one and group meetings.

  • Canaccord’s Cannabis Virtual Conference

    May 11, 2021

    Boris Jordan, Curaleaf Executive Chairman, will be participating in a fireside chat hosted by Canaccord Genuity Corp. Equity Analyst Matt Bottomley, CPA, CA, CBV. (9:00am9:25am) Curaleaf management will also be hosting investor one-on-one and group meetings.

  • Prohibition Partners LIVE

    May 20, 2021

    Boris Jordan, Curaleaf Executive Chairman, will be participating in a fireside discussion titled, “Curaleaf Holdings Across the Pond: Why Europe, Why Now?” with Financial Times Reporter, Patricia Nilsson, with an in depth look at Curaleaf’s exciting steps into the European Market. (9:30am10:00am)

For more information regarding upcoming Curaleaf financial community conference and event participation as well as details to access the webcasts please visit Curaleaf’s IR website at https://ir.curaleaf.com/events.  

About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 106 dispensaries, 23 cultivation sites, more than 30 processing sites, and employs over 4,800 team members. Curaleaf International is the largest vertically integrated independent cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with leading cultivation, extraction and production capabilities. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com/.

INVESTOR CONTACT
Curaleaf Holdings, Inc. 
Carlos Madrazo, SVP, Investor Relations and Capital Markets
[email protected]

MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady, VP Corporate Communications
[email protected]

Cision View original content:http://www.prnewswire.com/news-releases/curaleaf-announces-upcoming-investor-community-conference-and-event-participation-301282464.html

SOURCE Curaleaf Holdings, Inc.

Kennametal Announces Fiscal 2021 Third Quarter Results

– Sales of $485 million increased 10 percent sequentially, outperforming expectations

– Strong third quarter cash generation delivering year-to-date cash flow from operations of $139 million and free operating cash flow of $46 million

– Third quarter incremental simplification/modernization benefits of approximately $18 million, $180 million of cumulative program savings expected by end of FY21

– Fourth quarter sales expected to be up mid-single digits sequentially from continued market recovery and commercial excellence

PR Newswire

PITTSBURGH, May 3, 2021 /PRNewswire/ — Kennametal Inc. (NYSE: KMT) (the “Company”) today reported results for its fiscal 2021 third quarter ended March 31, 2021, with earnings per diluted share (EPS) of $0.26, compared with $0.03 in the prior year quarter, and adjusted EPS of $0.32, compared with $0.46 in the prior year quarter.

“I am encouraged by our results, which reflect solid execution of our initiatives as well as improving sales and free operating cash flow. Sales increased 10 percent sequentially, exceeding expectations, with improvement across all end-markets and regions and a return to growth on a year-over-year basis in Transportation, General Engineering and Asia Pacific. Although near-term uncertainties remain due to customer supply chain constraints and the effects of ongoing COVID-19 restrictions, we are optimistic that the worst of this crisis is behind us, and the momentum of the recovery will continue,” said Christopher Rossi, President and CEO.

Rossi added: “Adjusted operating margins increased 330 basis points sequentially due to stronger sales and improved manufacturing productivity. This margin improvement was achieved despite the continued lifting of temporary cost control actions. We expect further margin improvement in the fourth quarter through disciplined execution of our commercial excellence and simplification/modernization initiatives along with improving market conditions. We remain confident in our ability to deliver strong operating leverage and free operating cash flow as markets continue to recover and throughout the cycle.”


Simplification/Modernization Update

The Company has achieved annualized savings since inception to date from simplification/modernization of $164 million and is on track to achieve the $180 million savings target set at Investor Day in December 2017. Total incremental benefits in the quarter were approximately $18 million, which includes incremental restructuring savings of approximately $13 million as noted in the table below.


RESTRUCTURING AND RELATED CHARGES AND SAVINGS (PRE-TAX)


($ in millions)


Charges


Approximate Savings


Programs


Total Estimated


Current Quarter


Inception to Date


Total Estimated


YoY Incremental Current Quarter


Annualized Inception to Date

FY21 Actions

$90 – $95

$2

$77

$75

$13

$58


Fiscal 2021 Third Quarter Key Developments

Sales of $485 million increased 10 percent sequentially from the second quarter. Compared to the prior year’s third quarter, sales were relatively flat from $483 million, reflecting a favorable currency exchange effect of 2 percent, offset by organic sales decline and unfavorable business day effects of 1 percent, respectively.

Operating income was $40 million, or 8.2 percent of sales, compared to $38 million, or 7.8 percent of sales, in the prior year quarter. The increase in operating income was due primarily to approximately $18 million of incremental simplification/modernization benefits, no goodwill and other intangible asset impairment charges in the current year quarter and $2 million of restructuring and related charges compared to $6 million in the prior year quarter, largely offset by an increase in variable compensation, unfavorable geographic and product mix, and unfavorable labor and fixed cost absorption due to lower volumes. Adjusted operating income was $42 million, or 8.6 percent margin, compared to $59 million, or 12.2 percent margin, in the prior year quarter.

The reported effective tax rate (ETR) for the quarter was 8.0 percent (benefit on income) and the adjusted ETR was 20.6 percent (provision on income), compared to reported ETR of 93.1 percent and adjusted ETR of 28.5 percent in the prior year quarter, both provisions on income. The year-over-year change in the reported ETR is due primarily to changes in projected pretax income in both periods, discrete tax benefits recorded in the current year quarter related to the early debt extinguishment and a provision to return adjustment, as well as certain events that did not repeat in the current year such as goodwill and other intangible asset impairments. The decrease in the adjusted ETR is due primarily to a discrete tax benefit related to a provision to return adjustment and lower U.S. taxes associated with the base erosion anti-abuse tax (BEAT) and global intangible low-taxed income (GILTI) tax.

Reported EPS in the current quarter includes restructuring and related charges of $0.02, the effects of the early debt extinguishment of $0.08 and differences in annual projected tax rates of $0.08, partially offset by a discrete tax benefit of $0.12. Reported EPS in the prior year quarter includes restructuring and related charges of $0.06, goodwill and other intangible asset impairment charges of $0.17 and differences in annual projected tax rates of $0.20.

During the third quarter, the Company issued $300 million of 2.80 percent Senior Unsecured Notes with a maturity date of March 1, 2031 and subsequently used the net proceeds from the issuance, plus cash on hand, for the early extinguishment of the $300 million of 3.875 percent Senior Unsecured Notes due February 2022. 

Year-to-date net cash flow provided by operating activities was $139 million compared to $146 million in the prior year period. The change in net cash flow provided by operating activities was driven primarily by working capital adjustments. Year-to-date free operating cash flow (FOCF) was $46 million compared to negative $57 million in the prior year period. The improvement in FOCF was driven primarily by lower capital expenditures of $112 million, partially offset by working capital adjustments.


Outlook and Fourth Quarter Assumptions

While the economic recovery is certainly underway, overall global market conditions remain somewhat unpredictable due to customer supply chain challenges, notably the semiconductor shortage issue in Transportation, and uncertainty from COVID-19 related restrictions, primarily in EMEA and parts of Asia Pacific.

From an outlook perspective for the fourth quarter, the Company’s expectations are as follows:

  • Sales are expected to be up mid-single digits sequentially
  • Adjusted operating margin is expected to modestly improve sequentially
  • Capital spending is expected to be approximately $120 million for FY21

The Company will provide more details regarding its fourth quarter assumptions on its conference call.


Segment Results

Metal Cutting sales of $308 million increased 9 percent sequentially from the second quarter outpacing the typical seasonal trend. Compared to the prior year’s third quarter, sales increased 2 percent from $303 million year-over-year, driven by a favorable currency exchange effect of 3 percent, partially offset by an unfavorable business day effect of 1 percent. Operating income was $23 million, or 7.4 percent of sales, compared to $17 million, or 5.5 percent of sales, in the prior year quarter. The increase in operating income was due primarily to approximately $11 million of incremental simplification/modernization benefits, no goodwill and other intangible asset impairment charges in the current year quarter and $2 million of restructuring and related charges compared to $4 million in the prior year quarter, partially offset by an increase in variable compensation, unfavorable product mix and unfavorable labor and fixed cost absorption due to lower volumes. Adjusted operating income was $25 million, or 8.2 percent margin, compared to $36 million, or 12.0 percent margin, in the prior year quarter.

Infrastructure sales of $177 million increased 12 percent sequentially from the second quarter, but decreased 2 percent from $180 million year-over-year, driven by an organic sales decline of 3 percent and an unfavorable business day effect of 1 percent, partially offset by a favorable currency exchange effect of 2 percent. Operating income was $18 million, or 10.4 percent of sales, compared to $22 million, or 12.2 percent of sales, in the prior year quarter. The decrease in operating income was primarily driven by an increase in variable compensation, organic sales decline and unfavorable labor and fixed cost absorption due to lower volumes, partially offset by approximately $4 million of incremental simplification/modernization benefits. Adjusted operating income was $18 million, or 10.1 percent margin, compared to $23 million, or 13.0 percent margin, in the prior year quarter.


Dividend Declared

Kennametal also announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share. The dividend is payable on May 25, 2021 to shareholders of record as of the close of business on May 11, 2021.

The Company will host a conference call to discuss its third quarter fiscal 2021 results on Tuesday, May 4, 2021 at 8:00 a.m. Eastern Time. The conference call will be broadcast via real-time audio on the Kennametal website at www.kennametal.com. Once on the homepage, select “About Us”, “Investor Relations” and then “Events.”

This earnings release contains non-GAAP financial measures. Reconciliations and descriptions of all non-GAAP financial measures are set forth in the tables that follow.

Certain statements in this release may be forward-looking in nature, or “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are statements that do not relate strictly to historical or current facts. For example, statements about Kennametal’s outlook for earnings, sales volumes, cash flow, capital expenditures and effective tax rate for fiscal year 2021 and our expectations regarding future growth and financial performance are forward-looking statements. Any forward-looking statements are based on current knowledge, expectations and estimates that involve inherent risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should the assumptions underlying the forward-looking statements prove incorrect, our actual results could vary materially from our current expectations. There are a number of factors that could cause our actual results to differ from those indicated in the forward-looking statements. They include: the duration of the COVID-19 pandemic and its impacts on our business operations, financial results and financial position and on the industries in which we operate and the global economy generally; other downturns in the business cycle or the economy; our ability to achieve all anticipated benefits of restructuring, simplification and modernization initiatives; risks related to our foreign operations and international markets, such as currency exchange rates, different regulatory environments, trade barriers, exchange controls, and social and political instability; changes in the regulatory environment in which we operate, including environmental, health and safety regulations; potential for future goodwill and other intangible asset impairment charges; our ability to protect and defend our intellectual property; continuity of information technology infrastructure; competition; our ability to retain our management and employees; demands on management resources; availability and cost of the raw materials we use to manufacture our products; product liability claims; integrating acquisitions and achieving the expected savings and synergies; global or regional catastrophic events; demand for and market acceptance of our products; business divestitures; labor relations; and implementation of environmental remediation matters. Many of these risks and other risks are more fully described in our latest annual report on Form 10-K and our other periodic filings with the Securities and Exchange Commission. We can give no assurance that any goal or plan set forth in forward-looking statements can be achieved and readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. We undertake no obligation to release publicly any revisions to forward-looking statements as a result of future events or developments.

About Kennametal

With over 80 years as an industrial technology leader, Kennametal Inc. delivers productivity to customers through materials science, tooling and wear-resistant solutions. Customers across aerospace, earthworks, energy, general engineering and transportation turn to Kennametal to help them manufacture with precision and efficiency. Every day approximately 9,000 employees are helping customers in more than 60 countries stay competitive. Kennametal generated nearly $1.9 billion in revenues in fiscal 2020. Learn more at www.kennametal.com. Follow @Kennametal: Twitter, Instagram, Facebook, LinkedIn and YouTube.


FINANCIAL HIGHLIGHTS


CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)


Three Months Ended March 31,


Nine Months Ended March 31,


(in thousands, except per share amounts)


2021


2020


2021


2020

Sales

$

484,658

$

483,084

$

1,325,470

$

1,506,252

Cost of goods sold

334,483

326,066

948,693

1,078,236

  Gross profit

150,175

157,018

376,777

428,016

Operating expense

108,113

98,534

299,211

320,273

Restructuring and asset impairment charges

(822)

17,187

26,145

84,182

Loss on divestiture

6,517

Amortization of intangibles

3,362

3,404

10,043

10,413

  Operating income

39,522

37,893

41,378

6,631

Interest expense

20,928

7,897

39,823

23,834

Other income, net

(2,692)

(2,438)

(10,568)

(9,330)

Income (loss) before income taxes

21,286

32,434

12,123

(7,873)

Provision (benefit) for income taxes

(1,699)

30,193

(10,252)

(11,295)

Net income

22,985

2,241

22,375

3,422

Less: Net income (loss) attributable to noncontrolling interests

1,364

(676)

3,042

(23)

Net income attributable to Kennametal

$

21,621

$

2,917

$

19,333

$

3,445

PER SHARE DATA ATTRIBUTABLE TO KENNAMETAL SHAREHOLDERS

Basic earnings per share

$

0.26

$

0.04

$

0.23

$

0.04

Diluted earnings per share

$

0.26

$

0.03

$

0.23

$

0.04

Basic weighted average shares outstanding

83,719

83,106

83,539

83,022

Diluted weighted average shares outstanding

84,588

83,696

84,184

83,589

 


CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)


(in thousands)


March 31, 2021


June 30, 2020

 


 ASSETS

Cash and cash equivalents

$

114,307

$

606,684

Accounts receivable, net

303,210

237,983

Inventories

476,164

522,447

Other current assets

73,235

73,698


Total current assets

966,916

1,440,812

Property, plant and equipment, net

1,053,989

1,038,271

Goodwill and other intangible assets, net

399,735

403,148

Other assets

194,340

155,360


Total assets

$

2,614,980

$

3,037,591

 


 LIABILITIES

Revolving and other lines of credit and notes payable

$

18,745

$

500,368

Accounts payable

164,481

164,641

Other current liabilities

242,327

233,071


Total current liabilities

425,553

898,080

Long-term debt

591,672

594,083

Other liabilities

280,174

276,640


Total liabilities

1,297,399

1,768,803


KENNAMETAL SHAREHOLDERS’ EQUITY

1,276,412

1,229,885


NONCONTROLLING INTERESTS

41,169

38,903


Total liabilities and equity

$

2,614,980

$

3,037,591

 








SEGMENT DATA (UNAUDITED)


Three Months Ended March 31,


Nine Months Ended March 31,


(in thousands)


2021


2020


2021


2020


Outside Sales:

Metal Cutting

$

308,144

$

303,459

838,937

951,123

Infrastructure

176,514

179,625

486,533

555,129

Total sales

$

484,658

$

483,084

$

1,325,470

$

1,506,252


Sales By Geographic Region:

Americas

$

217,236

$

242,404

591,128

746,936

EMEA

152,557

146,847

412,538

450,760

Asia Pacific

114,865

93,833

321,804

308,556

Total sales

$

484,658

$

483,084

$

1,325,470

$

1,506,252


Operating income:

Metal Cutting

$

22,674

$

16,619

12,741

749

Infrastructure

18,282

21,941

31,815

7,679

Corporate (1)

(1,434)

(667)

(3,178)

(1,797)

Total operating income

$

39,522

$

37,893

$

41,378

$

6,631


(1)
 Represents unallocated corporate expenses.

NON-GAAP RECONCILIATIONS (UNAUDITED)

In addition to reported results under generally accepted accounting principles in the United States of America (GAAP), the following financial highlight tables include, where appropriate, a reconciliation of adjusted results including: operating income and margin; ETR; net income attributable to Kennametal; diluted EPS; Metal Cutting operating income and margin; Infrastructure operating income and margin; FOCF; and consolidated and segment organic sales growth (decline) (all of which are non-GAAP financial measures), to the most directly comparable GAAP financial measures. Adjustments for the three months ended March 31, 2021 include restructuring and related charges, effects of early debt extinguishment, discrete tax benefits and differences in projected annual tax rates. Adjustments for the three months ended March 31, 2020 include restructuring and related charges, goodwill and other intangible asset impairment charges and differences in projected annual tax rates. For those adjustments that are presented ‘net of tax’, the tax effect of the adjustment can be derived by calculating the difference between the pre-tax and the post-tax adjustments presented. The tax effect on adjustments is calculated by preparing an overall tax calculation including the adjustments and then a tax calculation excluding the adjustments. The difference between these calculations results in the tax impact of the adjustments.

Management believes that presentation of these non-GAAP financial measures provides useful information about the results of operations of the Company for the current and past periods. Management believes that investors should have available the same information that management uses to assess operating performance, determine compensation and assess the capital structure of the Company. These non-GAAP financial measures should not be considered in isolation or as a substitute for the most comparable GAAP financial measures. Investors are cautioned that non-GAAP financial measures used by management may not be comparable to non-GAAP financial measures used by other companies. Reconciliations and descriptions of all non-GAAP financial measures are set forth in the disclosures below.


THREE MONTHS ENDED MARCH 31, 2021 (UNAUDITED)


(in thousands, except percents and per share data)


Sales


Operating income


ETR


Net  income(2)


Diluted EPS

Reported results

$

484,658

$

39,522

(8.0)

%

$

21,621

$

0.26

Reported operating margin

8.2

%

Restructuring and related charges

2,082

28.6

1,478

0.02

Effects of early debt extinguishment

48.6

6,438

0.08

Discrete tax benefit

(43.5)

(9,268)

(0.12)

Differences in projected annual tax rates

(5.1)

6,869

0.08

Adjusted results

$

484,658

$

41,604

20.6

%

$

27,138

$

0.32

Adjusted operating margin

8.6

%


(2) Attributable to Kennametal.


THREE MONTHS ENDED MARCH 31, 2021 (UNAUDITED)


Metal Cutting


Infrastructure


(in thousands, except percents)


Sales


Operating income


Sales


Operating income

Reported results

$

308,144

$

22,674

$

176,514

$

18,282

Reported operating margin

7.4

%

10.4

%

Restructuring and related charges

2,522

(441)

Adjusted results

$

308,144

$

25,196

$

176,514

$

17,841

Adjusted operating margin

8.2

%

10.1

%

 


THREE MONTHS ENDED MARCH 31, 2020 (UNAUDITED)


(in thousands, except percents and per share data)


Sales


Operating  income


ETR


Net  income(2)


Diluted EPS

Reported results

$

483,084

$

37,893

93.1

%

$

2,917

$

0.03

Reported operating margin

7.8

%

Restructuring and related charges

5,573

12.8

4,858

0.06

Goodwill and other intangible asset impairment charges

15,599

3.1

14,261

0.17

Differences in projected annual tax rates

(80.5)

16,106

0.20

Adjusted results

$

483,084

$

59,065

28.5

%

$

38,142

$

0.46

Adjusted operating margin

12.2

%


(2) Attributable to Kennametal.


THREE MONTHS ENDED MARCH 31, 2020 (UNAUDITED)


Metal Cutting


Infrastructure


(in thousands, except percents)


Sales


Operating income


Sales


Operating income

Reported results

$

303,459

$

16,619

$

179,625

$

21,941

Reported operating margin

5.5

%

12.2

%

Restructuring and related charges

4,149

1,423

Goodwill and other intangible asset impairment charges

15,599

Adjusted results

$

303,459

$

36,367

$

179,625

$

23,364

Adjusted operating margin

12.0

%

13.0

%

Free Operating Cash Flow (FOCF)

FOCF is a non-GAAP financial measure and is defined by the Company as net cash flow provided by operating activities (which is the most directly comparable GAAP financial measure) less capital expenditures plus proceeds from disposals of fixed assets. Management considers FOCF to be an important indicator of the Company’s cash generating capability because it better represents cash generated from operations that can be used for dividends, debt repayment, strategic initiatives (such as acquisitions) and other investing and financing activities.


FREE OPERATING CASH FLOW (UNAUDITED)


Nine Months Ended March 31,


(in thousands)


2021


2020

Net cash flow provided by operating activities

$

139,197

$

146,059

Purchases of property, plant and equipment

(94,066)

(206,061)

Disposals of property, plant and equipment

1,216

2,780

Free operating cash flow

$

46,347

$

(57,222)

Organic Sales Growth

Organic sales growth (decline) is a non-GAAP financial measure of sales growth (decline) (which is the most directly comparable GAAP measure) excluding the effects of acquisitions, divestitures, business days and foreign currency exchange from year-over-year comparisons. Management believes this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth (decline) on a consistent basis. Management reports organic sales growth (decline) at the consolidated and segment levels.


ORGANIC SALES GROWTH (DECLINE) (UNAUDITED)


Three Months Ended March 31, 2021


Metal Cutting


Infrastructure


Total

Organic sales growth (decline)

—%

(3)%

(1)%

Foreign currency exchange effect (3)

3

2

2

Business days effect (4)

(1)

(1)

(1)

Sales growth (decline)

2%

(2)%

—%


(3) Foreign currency exchange effect is calculated by dividing the difference between current period sales and current period sales at prior period foreign exchange rates by prior period sales.


(4) Business days effect is calculated by dividing the year-over-year change in weighted average working days (based on mix of sales by country) by prior period weighted average working days.

 

Cision View original content:http://www.prnewswire.com/news-releases/kennametal-announces-fiscal-2021-third-quarter-results-301282457.html

SOURCE Kennametal Inc.

B. Riley Financial Reports First Quarter 2021 Results; Declares $3.00 Dividend

Reports net income of $252.9 million, diluted EPS of $8.81

Total revenues of $600.2 million, operating revenues of $333.2 million

Total adjusted EBITDA of $385.5 million, operating EBITDA of $122.7 million

Declares dividend of $3.00 per share, includes $0.50 regular and $2.50 special

PR Newswire

LOS ANGELES, May 3, 2021 /PRNewswire/ — B. Riley Financial, Inc. (NASDAQ: RILY), a diversified financial services company, today announced its financial results for the first quarter ended March 31, 2021.

First Quarter 2021 Highlights

  • Net income available to common shareholders of $252.9 million, or $8.81 per diluted share
  • Total quarterly revenues of $600.2 million, total adjusted EBITDA (1) of $385.5 million
  • Operating revenues (2) of $333.2 million vs. $182.2 million for Q1 2020
  • Operating adjusted EBITDA (3) of $122.7 million vs. $70.9 million for Q1 2020
  • Investment gains (4) of $266.9 million as of March 31, 2021
  • Completed acquisition of National Holdings, enhancing wealth management and capital markets
  • Declared total quarterly dividend of $3.00 per common share

Bryant Riley, Chairman and Co-Chief Executive Officer of B. Riley Financial, said: “Our first quarter performance again demonstrates the combined platform’s strength and earnings power, with this period driven by particularly exceptional results from our investment banking group. Our results were enhanced by investment gains of approximately $267 million, coupled with a year-over-year increase of over 80 percent and 70 percent, respectively, for quarterly operating revenues and operating EBITDA. These results reflected the upside from capital markets in addition to steady and recurring contributions from the balance of our businesses.”

Tom Kelleher, Co-Chief Executive Officer of B. Riley Financial, added: “During the quarter, we completed the acquisition of National Holdings and welcomed nearly 700 registered representatives to B. Riley. With $31 billion in combined assets as of March 31, the addition of National to wealth management creates meaningful scale and distribution for our overall platform.”

“We also added a new risk and compliance practice that is in high demand by our customers and enhances our advisory services. As we continue to build on and deepen our core capabilities in capital markets, restructuring and advisory, we are seeing more opportunities and increased collaboration across our businesses,” Kelleher stated. “With the diversity of our platform, we believe B. Riley is exceptionally well-positioned to support our clients and partners through both up and downcycles.”

Riley added, “Our dividend of $3.00 per share approximates our operating free cash flow generated during the quarter and amounts to over $350 million in total capital distributed to our shareholders through dividends and share repurchases since 2017. With a quarter-end balance sheet supported by over $650 million in cash and investments net of debt, we feel a meaningful capital return policy is consistent with our shareholder commitment while allowing us to continue to aggressively invest in our business. We believe in the strength of our people and our platform to continue to deliver for all of our stakeholders in the years ahead.”

Declaration of Common Stock Dividend
The Company’s Board of Directors has approved a total quarterly dividend of $3.00 per share which includes the regular $0.50 dividend and a special dividend of $2.50 per share. The dividend is payable on or about May 28, 2021 to common stockholders of record as of May 17, 2021.

First Quarter 2021 Financial Summary
For the three months ended March 31, 2021, B. Riley Financial reported net income available to common shareholders of $252.9 million, or $8.81 per diluted share.


Three Months Ended


March 31,


(Dollars in thousands, except for share data)


2021


2020

Net income (loss) available to common shareholders

$

252,907

$

(99,720)

Basic income (loss) per common share 

$

9.38

$

(3.83)

Diluted income (loss) per common share 

$

8.81

$

(3.83)

Total quarterly revenues of $600.2 million and total adjusted EBITDA (1) of $385.5 million represented a significant increase versus the prior-year quarter.


Three Months Ended


March 31,


(Dollars in thousands)


2021


2020

    Operating Revenues (2)

$

333,217

$

182,236

    Investment Gains (Loss)(4)

266,942

(182,442)


        Total Revenues


$


600,159


$


(206)

   Operating Adjusted EBITDA (3)

$

122,717

$

70,908

   Investment Adjusted EBITDA (5)

262,764

(166,972)


       Total Adjusted EBITDA (1)


$


385,481


$


(96,064)

First quarter operating revenues (2) of $333.2 million represented an 83% increase from $182.2 million for the prior-year period. Operating adjusted EBITDA (3) increased by 73% to $122.7 million from $70.9 million for the prior-year period.

Operating results were enhanced by significant investment gains (4) of $266.9 million for the first quarter. Investment gains are primarily unrealized mark-to-market valuations on strategic investments held by the Company. These investments comprise certain private and public securities and loans which are often enhanced through utilization of the Company’s strategic advisory, operational and financial services.

As of March 31, 2021, cash and investments (6) totaled approximately $1.9 billion including cash and cash equivalents of $237.6 million. Total cash and investments, (6) net of debt, was $653.8 million at quarter-end.

Additional Metrics and Supplemental Financial Data
Additional metrics related to operating results and investments are presented to provide investors with greater visibility into the Company’s performance and overall results of operations. Further details related to these metrics can be found in B. Riley Financial’s First Quarter 2021 Financial Supplement located on the Company’s investor relations website.

First Quarter 2021 Segment Summary


    Operating Revenues(2)


    Investment Gains (Loss) (4)


Total Segment Revenue


Three Months Ended March 31,


Three Months Ended March 31,


Three Months Ended March 31,


(Dollars in thousands)


2021


2020


2021


2020


2021


2020

Capital Markets

207,899

95,451

264,503

(182,015)

472,402

(86,564)

Wealth Management

65,542

18,887

2,356

(427)

67,898

18,460

Auction and Liquidation

13,450

20,661

13,450

20,661

Financial Consulting

21,409

20,714

21,409

20,714

Principal Investments

20,529

22,722

20,529

22,722

Brands

4,388

3,801

83

4,471

3,801


Segment Operating Income (Loss)(7)


    Investment Income (Loss) (5)


Total Segment Income (Loss)


Three Months Ended March 31,


Three Months Ended March 31,


Three Months Ended March 31,


(Dollars in thousands)


2021


2020


2021


2020


2021


2020

Capital Markets

105,983

42,611

260,325

(166,545)

366,308

(123,934)

Wealth Management

1,671

856

2,356

(427)

4,027

429

Auction and Liquidation

907

4,289

907

4,289

Financial Consulting

3,322

4,918

3,322

4,918

Principal Investments

7,531

8,504

7,531

8,504

Brands

2,998

(1,817)

83

3,081

(1,817)

For the first quarter of 2021:

  • Excluding investment gains, Capital Markets operating revenues increased 118% to $207.9 million from $95.5 million from the prior-year period. Segment operating income (7) totaled $106.0 million. Investment banking experienced an exceptionally strong quarter driven by a number of large transactions.
  • Wealth Management revenues of $67.9 million reflected contributions from the acquisition of National Holdings completed on February 25, 2021. Combined client assets under management totaled approximately $31 billion as of March 31, 2021.
  • Auction and Liquidation segment results included revenues of $13.5 million earned from retail store closing projects completed during the quarter. Results for this segment vary from quarter-to-quarter and year-to-year due to the episodic impact of large retail liquidation engagements.
  • Financial Consulting revenues increased to $21.4 million compared to revenues of $20.7 million for the prior-year period. Segment income was $3.3 million. Results were primarily driven by bankruptcy restructuring and appraisal engagements.
  • Principal Investments companies, magicJack and United Online, contributed revenues of $20.5 million and segment income of $7.5 million. magicJack and United Online continued to perform above expectations, contributing recurring cash flow to the Company.
  • Brands generated revenues of $4.5 million and segment income of $3.1 million related to the licensing of brand trademarks.

Segment Reclassification
The Company has realigned its segment reporting structure as a result of the National acquisition. Under the new structure, results for wealth management are now reported as a standalone segment. Wealth management was previously reported in the Capital Markets segment. In conjunction with the new reporting structure, the Company has recast its segment presentation for all periods presented.

Conference Call Details
B. Riley Financial will host a conference call to discuss its first quarter 2021 financial results at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) today, Monday May 3, 2021. Investors may access the live broadcast and archived recording via the Company’s investor relations website.

Date and Time: 

Monday May 3, 2021 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time)

Dial In: 

1-855-327-6838 (toll-free) or 1-604-235-2082 (international)

Audio Webcast: 


https://ir.brileyfin.com/events-and-presentations

Replay (expires Monday, May 10, 2021)

Dial In: 

1-844-512-2921; 10013967 (pin)

Replay Link: 


https://ir.brileyfin.com/events-and-presentations

About B. Riley Financial
B. Riley Financial is a diversified financial services company that provides collaborative solutions tailored to fit the capital raising and business advisory needs of its clients and partners. B. Riley operates through several subsidiaries that offer a diverse range of complementary end-to-end capabilities spanning investment banking and institutional brokerage, private wealth and investment management, financial consulting, corporate restructuring, operations management, risk and compliance, due diligence, forensic accounting, litigation support, appraisal and valuation, auction and liquidation services. Certain registered affiliates originate and underwrite senior secured loans for asset-rich companies. B. Riley also makes proprietary investments in companies and assets with attractive return profiles. For the latest news and developments, follow us on LinkedIn and Twitter @BRileyFinancial. For more information, visit www.brileyfin.com.

B. Riley refers to B. Riley Financial and/or one or more of its subsidiaries or affiliates. For more information about our affiliated companies, visit www.brileyfin.com/platform.

Footnotes (See “Note Regarding Use of Non-GAAP Financial Measures” for further discussion of these non-GAAP terms.)

(1)

Adjusted EBITDA includes earnings before interest, taxes, depreciation, amortization, restructuring costs, share-based payments, impairment of tradenames, and transaction related and other costs. For a definition of adjusted EBITDA and a reconciliation to GAAP financial measures, please see the Appendix hereto.

(2)

Operating revenue is defined as the sum of revenues from services and fees, interest income – loans and securities lending, and sale of goods.

(3)

Operating adjusted EBITDA is defined as adjusted EBITDA excluding trading income (losses) and fair value adjustments on loans and other investment related expenses.

(4)

Investment gains is defined as trading income and fair value adjustments on loans.

(5)

Investment adjusted EBITDA and investment gains income (loss) are defined as trading income and fair value adjustments on loans, less other investment related expenses.

(6)

Total cash and investments is defined as the sum of cash and cash equivalents, restricted cash, due from clearing brokers net of due to clearing brokers, securities and other investments owned, at fair value net of (i) securities sold not yet purchased and (ii) other investments participation sold reported in noncontrolling interest, advances against customer contracts, loans receivable, at fair value net of loan participations sold, and other equity investments reported in prepaid and other assets.

(7)

Segment operating income is defined as segment income excluding trading income (losses) and fair value adjustments on loans and other investment related expenses.

Note Regarding Use of Non-GAAP Financial Measures
Certain of the information set forth herein, including operating revenues, adjusted EBITDA, operating adjusted EBITDA, and investment adjusted EBITDA may be considered non-GAAP financial measures. B. Riley Financial believes this information is useful to investors because it provides a basis for measuring the Company’s available capital resources, the operating performance of its business and its revenues and cash flow, (i) excluding in the case of operating revenues, trading income (losses) and fair value adjustments on loans, (ii) excluding in the case of adjusted EBITDA, net interest expense, provisions for or benefit from income taxes, depreciation, amortization, fair value adjustment, restructuring costs, impairment of trade names, stock-based compensation and transaction and other expenses, (iii) excluding in the case of operating adjusted EBITDA, the aforementioned adjustments for adjusted EBITDA as well as trading income (losses) and fair value adjustments on loans, and other investment related expenses, (iv) including in the case of investment adjusted EBITDA, trading income (losses) and fair value adjustments on loans, net of other investment related expenses, and (v) including in the case of total cash and investments, net of debt, total cash, net securities and investments, and other minus total debt, that would normally be included in the most directly comparable measures calculated and presented in accordance with Generally Accepted Accounting Principles (“GAAP”). In addition, the Company’s management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measures in evaluating the Company’s operating performance, capital resources and cash flow. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP, and non-financial measures as reported by the Company may not be comparable to similarly titled amounts reported by other companies.

Forward-Looking Statements
Statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management’s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition, and stock price could be materially negatively affected. You should not place undue reliance on such forward-looking statements, which are based on the information currently available to us and speak only as of the date of this press release. Such forward-looking statements include, but are not limited to, statements regarding the Company’s anticipated results of operations for 2021, as well as statements regarding our excitement and the expected growth of our business segments. Factors that could cause such actual results to differ materially from those contemplated or implied by such forward-looking statements include, without limitation, the risks associated with the unpredictable and ongoing impact of the COVID-19 pandemic and other risks described from time to time in B. Riley Financial, Inc.’s periodic filings with the SEC, including, without limitation, the risks described in B. Riley Financial, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2020 under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (as applicable). Additional information will be set forth in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. All information is current as of the date this press release is issued, and B. Riley Financial, Inc. undertakes no duty to update this information.


Contacts


Investors


Media

Mike Frank

Jo Anne McCusker


[email protected] 


[email protected]

(212) 409-2424

(646) 885-5425

 


B. RILEY FINANCIAL, INC.


Condensed Consolidated Balance Sheets


(Dollars in thousands, except par value)


March 31,


December 31,


2021


2020


(Unaudited)


Assets

Assets:

Cash and cash equivalents

$

237,590

$

103,602

Restricted cash

8,532

1,235

Due from clearing brokers

416,925

7,089

Securities and other investments owned, at fair value

1,166,704

777,319

Securities borrowed

1,313,635

765,457

Accounts receivable, net

62,425

46,518

Due from related parties

1,079

986

Advances against customer contracts

200

200

Loans receivable, at fair value (includes $200,118 and $295,809 from related parties at

March 31, 2021 and December 31, 2020, respectively)

294,085

390,689

Prepaid expenses and other assets

92,812

87,262

Operating lease right-of-use assets

60,518

48,799

Property and equipment, net

15,295

11,685

Goodwill

233,807

227,046

Other intangible assets, net

205,439

190,745

Deferred tax assets, net

2,765

4,098

     Total assets

$

4,111,811

$

2,662,730


Liabilities and Equity

Liabilities:

Accounts payable

$

7,487

$

2,722

Accrued expenses and other liabilities

267,164

168,478

Deferred revenue

68,515

68,651

Deferred tax liabilities, net

101,270

34,248

Due to related parties and partners

1,503

327

Due to clearing brokers

13,672

Securities sold not yet purchased

288,058

10,105

Securities loaned

1,307,069

759,810

Mandatorily redeemable noncontrolling interests

4,514

4,700

Operating lease liabilities

73,630

60,778

Notes payable

6,908

37,967

Loan participations sold

11,230

17,316

Term loan

69,543

74,213

Senior notes payable, net

1,139,100

870,783

     Total liabilities

3,345,991

2,123,770

Commitments and contingencies

B. Riley Financial, Inc. stockholders’ equity:

Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 3,971 shares issued and 

outstanding as of March 31, 2021 and December 31, 2020; and liquidation preference of $99,260

as of March 31, 2021 and December 31,2020.

Common stock, $0.0001 par value; 100,000,000 shares authorized; 27,194,909 and 25,777,796

issued and outstanding as of March 31, 2021 and December 31, 2020, respectively.

3

3

Additional paid-in capital

380,543

310,326

Retained earnings

352,910

203,080

Accumulated other comprehensive loss

(1,459)

(823)

     Total B. Riley Financial, Inc. stockholders’ equity

731,997

512,586

Noncontrolling interests

33,823

26,374

     Total equity

765,820

538,960

          Total liabilities and equity

$

4,111,811

$

2,662,730

 


B. RILEY FINANCIAL, INC.


Condensed Consolidated Statements of Income


(Unaudited)


(Dollars in thousands, except share data)


Three Months Ended


March 31,


2021


2020

Revenues:

Services and fees

$

289,469

$

159,381

Trading income (losses) and fair value adjustments on loans

266,942

(182,442)

Interest income – Loans and securities lending

36,920

21,851

Sale of goods

6,828

1,004

Total revenues

600,159

(206)

Operating expenses:

Direct cost of services

11,322

19,952

Cost of goods sold

5,326

769

Selling, general and administrative expenses

191,344

87,744

Impairment of tradenames

4,000

Interest expense – Securities lending and loan participations sold

19,189

8,473

Total operating expenses

227,181

120,938

Operating income (loss)

372,978

(121,144)

Other income (expense):

Interest income

49

246

Gain (loss) from equity investments

875

(236)

Interest expense

(19,786)

(15,654)

Income (loss) before income taxes

354,116

(136,788)

(Provision) benefit for income taxes

(97,518)

37,539

Net income (loss)

256,598

(99,249)

Net income (loss) attributable to noncontrolling interests

1,942

(584)

Net income (loss) attributable to B. Riley Financial, Inc.

$

254,656

$

(98,665)

Preferred stock dividends

1,749

1,055

Net income (loss) available to common shareholders

$

252,907

$

(99,720)

Basic income (loss) per common share 

$

9.38

$

(3.83)

Diluted income (loss) per common share 

$

8.81

$

(3.83)

Weighted average basic common shares outstanding

26,972,275

26,028,613

Weighted average diluted common shares outstanding

28,710,368

26,028,613

 


B. RILEY FINANCIAL, INC.


Condensed Consolidated Statements of Cash Flows


(Unaudited)


(Dollars in thousands)


Three Months Ended March 31,


2021


2020

Cash flows from operating activities:

Net income (loss) 

$

256,598

$

(99,249)

Adjustments to reconcile net income to net cash (used in) provided by operating activities:

     Depreciation and amortization

6,759

4,956

     Provision for doubtful accounts

402

724

     Share-based compensation

5,526

5,322

     Fair value adjustments, non-cash

(10,726)

17,926

     Non-cash interest and other

(4,375)

(2,827)

     Effect of foreign currency on operations

(726)

179

     (Income) loss from equity investments

(875)

236

     Dividends from equity investments

305

589

     Deferred income taxes

62,696

(4,254)

     Impairment of intangibles and gain on disposal of fixed assets

4,046

     Loss (gain) on extinguishment of debt

919

(1,556)

     Gain on equity investment

(3,544)

     Income allocated for mandatorily redeemable noncontrolling interests

130

175

     Change in operating assets and liabilities:

          Due from clearing brokers

(416,038)

12,939

          Securities and other investments owned

(235,504)

125,061

          Securities borrowed

(548,178)

140,168

          Accounts receivable and advances against customer contracts

(3,885)

15,674

          Prepaid expenses and other assets

(5,629)

(37,151)

          Accounts payable, accrued expenses and other liabilities

30,505

(22,097)

          Amounts due to/from related parties and partners

1,083

752

          Securities sold, not yet purchased

277,446

(27,522)

          Deferred revenue

(3,042)

6,589

          Securities loaned

547,259

(139,636)

               Net cash (used in) provided by operating activities

(42,894)

1,044

Cash flows from investing activities:

Purchases of loans receivable

(75,669)

(115,328)

Repayments of loans receivable

87,476

42,128

Sale of loan receivable to related party

1,800

Repayment of loan participations sold

(6,086)

(244)

Acquisition of business, net of $34,924 cash acquired

(260)

Purchases of property, equipment and other

(101)

(438)

Proceeds from sale of property, equipment and intangible assets

1

Purchase of equity investments

(4,698)

                Net cash provided by (used in) investing activities

662

(72,081)

Cash flows from financing activities:

Repayment of asset based credit facility

(37,096)

Repayment of notes payable 

(37,610)

(357)

Repayment of term loan

(4,750)

(4,810)

Proceeds from issuance of senior notes

402,404

171,078

Redemption of senior notes

(128,156)

(1,829)

Payment of debt issuance costs

(7,510)

(2,724)

Payment for contingent consideration

(75)

Payment of employment taxes on vesting of restricted stock

(22)

(505)

Common dividends paid

(95,183)

(9,609)

Preferred dividends paid

(1,749)

(1,055)

Repurchase of common stock

(24,068)

Distribution to noncontrolling interests

(11,571)

(1,323)

Contribution from noncontrolling interests

3,722

Proceeds from issuance of common stock

64,713

Proceeds from issuance of preferred stock

4,630

                Net cash provided by financing activities

184,213

92,332

                Increase in cash, cash equivalents and restricted cash

141,981

21,295

                Effect of foreign currency on cash, cash equivalents and restricted cash

(696)

(1,332)

                Net increase in cash, cash equivalents and restricted cash

141,285

19,963

Cash, cash equivalents and restricted cash, beginning of period

104,837

104,739

Cash, cash equivalents and restricted cash, end of period

$

246,122

$

124,702

Supplemental disclosures:

Interest paid

$

36,725

$

21,785

Taxes paid 

$

53

$

574

 


B. RILEY FINANCIAL, INC.


Segment Financial Information


(Unaudited)


(Dollars in thousands)


Three Months Ended


March 31,


2021


2020


Capital Markets segment:

Revenues – Services and fees

$

170,979

$

73,600

Trading income (losses) and fair value adjustments on loans

264,503

(182,015)

Interest income – Loans and securities lending

36,920

21,851

    Total revenues

472,402

(86,564)

Selling, general and administrative expenses

(86,140)

(28,301)

Interest expense – Securities lending and loan participations sold

(19,189)

(8,473)

Depreciation and amortization

(765)

(596)

    Segment income (loss)

366,308

(123,934)


Wealth Management segment:

Revenues – Services and fees

65,542

18,887

Trading income (losses) and fair value adjustments on loans

2,356

(427)

    Total revenues

67,898

18,460

Selling, general and administrative expenses

(61,472)

(17,548)

Depreciation and amortization

(2,399)

(483)

    Segment income

4,027

429


Auction and Liquidation segment:

Revenues – Services and fees

7,358

20,661

Revenues – Sale of goods

6,092

    Total revenues

13,450

20,661

Direct cost of services

(6,580)

(14,816)

Cost of goods sold

(4,474)

(29)

Selling, general and administrative expenses

(1,489)

(1,526)

Depreciation and amortization

(1)

    Segment income

907

4,289


Financial Consulting segment:

Revenues – Services and fees

21,409

20,714

Selling, general and administrative expenses

(17,989)

(15,729)

Depreciation and amortization

(98)

(67)

    Segment income

3,322

4,918


Principal Investments – United Online and magicJack segment:

Revenues – Services and fees

19,793

21,718

Revenues – Sale of goods

736

1,004

    Total revenues

20,529

22,722

Direct cost of services

(4,742)

(5,136)

Cost of goods sold

(852)

(740)

Selling, general and administrative expenses

(4,870)

(5,463)

Depreciation and amortization

(2,534)

(2,879)

    Segment income

7,531

8,504


Brands segment:

Revenues – Services and fees

4,388

3,801

Trading income and fair value adjustments on loans

83

    Total revenues

4,471

3,801

Selling, general and administrative expenses

(676)

(904)

Depreciation and amortization

(714)

(714)

Impairment of tradenames

(4,000)

    Segment income (loss)

3,081

(1,817)


Consolidated operating income (loss) from reportable segments


385,176


(107,611)

Corporate and other expenses (including (loss) gain on extinguishment of debt of

($919) and $1,556 during the three months ended March 31, 2021 and 2020, respectively.)

(12,198)

(13,533)

Interest income

49

246

Income (loss) on equity investments

875

(236)

Interest expense

(19,786)

(15,654)

Income (loss) before income taxes

354,116

(136,788)

(Provision) benefit for income taxes

(97,518)

37,539

Net income (loss) 

256,598

(99,249)

Net income (loss) attributable to noncontrolling interests

1,942

(584)

Net income (loss) attributable to B. Riley Financial, Inc.

254,656

(98,665)

Preferred stock dividends

1,749

1,055

Net income (loss) available to common shareholders

$

252,907

$

(99,720)

 


B. RILEY FINANCIAL, INC.


Adjusted EBITDA and Operating Adjusted EBITDA Reconciliation


(Unaudited)


(Dollars in thousands)


Three Months Ended
March 31,


2021


2020

Net income (loss) attributable to B. Riley Financial, Inc.

$

254,656

$

(98,665)

Adjustments:

Provision (benefit) for income taxes

97,518

(37,539)

Interest expense

19,786

15,654

Interest income

(49)

(246)

Share based payments

5,526

5,322

Depreciation and amortization

6,759

4,956

Impairment of tradenames

4,000

Transactions related costs and other

1,285

10,454

     Total EBITDA adjustments

130,825

2,601

          Adjusted EBITDA

$

385,481

$

(96,064)

Operating EBITDA Adjustments:

Trading (income) losses and fair value adjustments on loans

(266,942)

182,442

Other investment related expenses

4,178

(15,470)

     Total Operating EBITDA Adjustments

(262,764)

166,972

Operating Adjusted EBITDA

$

122,717

$

70,908

 


B. RILEY FINANCIAL, INC.


Adjusted Net Income Reconciliation


(Unaudited)


(Dollars in thousands, except share data)


Three Months Ended
March 31,


2021


2020

Net income (loss) attributable to B. Riley Financial, Inc.

$

254,656

$

(98,665)

Adjustments:

Share based payments

5,526

5,322

Amortization of intangible assets

5,886

4,024

Impairment of tradenames

4,000

Transactions related costs and other

1,285

10,454

Income tax effect of adjusting entries

(3,516)

(6,559)

Adjusted net income (loss) attributable to B. Riley Financial, Inc.

$

263,837

$

(81,424)

Adjusted income per common share:

Adjusted basic income (loss) per share 

$

9.78

$

(3.13)

Adjusted diluted income (loss) per share 

$

9.19

$

(3.13)

Shares used to calculate adjusted basic net income per share

26,972,275

26,028,613

Shares used to calculate adjusted diluted net income per share

28,710,368

26,028,613

 

Cision View original content:http://www.prnewswire.com/news-releases/b-riley-financial-reports-first-quarter-2021-results-declares-3-00-dividend-301282461.html

SOURCE B. Riley Financial

Semler Reports First Quarter 2021 Financial Results

2021 Q1 HIGHLIGHTS compared to the corresponding period of 2020:

– Revenues were $13.2 million, an increase of 40%

– Pre-tax net income of $6.0 million, an increase of $2.5 million, or 74%, compared to $3.5 million

– Net income was $4.9 million, or $0.73 per basic share and $0.60 per diluted share, compared to $2.7 million, or $0.41 per basic share and $0.33 per diluted share

– Cash at March 31, 2021 increased to $26.5 million from $11.2 million

PR Newswire

SANTA CLARA, Calif., May 3, 2021 /PRNewswire/ — Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three months ended March 31, 2021.

“Our intent is for the use of QuantaFlo® to become the standard of care for peripheral arterial disease (PAD) testing,” said Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific. “We are seeing growing awareness among primary care practitioners of the importance of prevention for their patients with PAD.”

FINANCIAL RESULTS

For the quarter ended March 31, 2021, compared to the quarter ended March 31, 2020, Semler Scientific reported:

  • Revenues of $13.2 million, an increase of $3.8 million, or 40%, compared to $9.4 million
  • Cost of revenues of $1.6 million, an increase of $0.7 million, or 86%, compared to $0.9 million. As a percentage of revenues, cost of revenues was 12%, compared to 9%
  • Total operating expenses, which includes cost of revenues, of $7.2 million, an increase of $1.2 million, or 20%, compared to $6.0 million
  • Pre-tax net income of $6.0 million, an increase of $2.5 million, or 74%, compared to $3.5 million
  • Net income of $4.9 million, or $0.73 per basic share and $0.60 per diluted share, an increase of $2.2 million, or 82%, compared to $2.7 million, or $0.41 per basic share and $0.33 per diluted share. As a percentage of revenues, net income was 37% compared to 28%
  • Cash of $26.5 million, an increase of $15.3 million, compared to $11.2 million

FIRST QUARTER 2021 MAJOR ACCOMPLISHMENTS

Among the achievements during the first quarter of 2021 were:

  1. Highest quarterly revenues since inception of the company.
  2. Consecutive quarterly profitability since the fourth quarter of 2017.
  3. Cash position increased to $26.5 million.

The company’s two largest customers comprised 38.3% and 30.4% of quarterly revenues.

In the first quarter of 2021 compared to the corresponding period of 2020, fixed fee license revenues were approximately $7.2 million, an increase of $0.7 million, or 11% compared to $6.5 million; variable fee license revenues were approximately $5.7 million, an increase of $3.0 million, or 109% compared to $2.7 million; and other product sales were were unchanged at  $0.3 million.

In 2021, Semler Scientific expects continued profitability and generation of cash from operating activities, as well as increased spending to support anticipated growth in its business. It is the company’s intent to grow annual revenues at a faster rate than annual expenses and to remain profitable.

OTHER SUBSEQUENT EVENTS

In April 2021, Semler Scientific entered into an exclusive marketing and distribution agreement for the United States, including Puerto Rico, except for selected accounts, with one of the companies in which it made a private investment in 2020. Under this distribution agreement, Semler Scientific agreed to purchase $2.0 million of product inventory.

Additionally, in April 2021, Semler Scientific exercised its option to “put” shares of one of its private company investments back to the sellers in exchange for the shares of Semler Scientific common stock originally issued to the sellers.  Following this transfer, Semler Scientific holds only the shares of preferred stock acquired in December 2020.

Notice of Conference Call

Semler Scientific will host a conference call today at 4:30 p.m. ET. The call will address results of the first quarter ended March 31, 2021 as well as provide a business update on the company’s market outlook and strategies for the near-term future.

Participants are encouraged to pre-register for the conference call using the following link: https://dpregister.com/sreg/10155556/e779a2c07c. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or who are unable to pre-register may dial in by calling:

Domestic callers: (866) 777–2509
International callers: (412) 317–5413

Please specify to the operator that you would like to join the “Semler Scientific Call.” The conference call will be archived on Semler Scientific’s website at www.semlerscientific.com.


Semler Scientific, Inc.


Statements of Income


Unaudited

(In thousands of U.S. Dollars, except for share and per share data)


For the three months ended March 31,


2021


2020

Revenues

$

13,183

$

9,430

Operating expenses:

Cost of revenues

1,579

850

Engineering and product development

693

842

Sales and marketing

2,816

2,695

General and administrative

2,076

1,591

Total operating expenses

7,164

5,978

Income from operations

6,019

3,452

Interest income

3

2

Other (expense)

(2)

(4)

Other income (expense)

1

(2)

Pre-tax net income

$

6,020

$

3,450

Income tax provision

$

1,143

$

777

Net income

$

4,877

$

2,673

Net income per share:

Basic

$

0.73

$

0.41

Diluted

$

0.60

$

0.33

Weighted average number of shares used in computing income per share:

Basic

6,710,990

6,533,369

Diluted

8,169,375

8,065,813

 


Semler Scientific, Inc.


Condensed Balance Sheets

(In thousands of U.S. Dollars)


At March 31,


At December 31,


2021


2020


Unaudited

Cash

$

26,478

$

22,079

Other current assets

6,807

4,524

Noncurrent assets

7,361

8,036

Total assets

40,646

34,639

Current liabilities

5,073

4,514

Noncurrent liabilities

305

332

Stockholders’ equity

35,268

29,793

Total liabilities and stockholders’ equity

$

40,646

$

34,639

About Semler Scientific, Inc.:

Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific’s mission is to develop, manufacture and market innovative proprietary products and services that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and U.S. Food and Drug Administration, or FDA, cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific’s customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care. Additional information about Semler Scientific can be found at semlerscientific.com.

Forward-Looking Statements

This press release contains “forward-looking” statements. Such statements can be identified by, among other things, the use of forward-looking language such as the words “may,” “will,” “intend,” “expect,” “anticipate,” “estimate,” “project,” “would,” “could” or words with similar meaning or the negatives of these terms or by the discussion of strategy or intentions. The forward-looking statements in this release include statements regarding continued profitability and cash generation from operations, the relative rate of revenue and expenses growth and ability to remain profitable, as well as increased spending, in addition to statements about the benefits of its service on patient outcomes and future expansion of its customer base. Such forward-looking statements are subject to a number of risks and uncertainties that could cause Semler Scientific’s actual results to differ materially from those discussed here, such as whether or not insurance plans and other customers will continue to license its cardiovascular testing products, and its ability to continue to control expenses and preserve cash, as well as uncertainty created by COVID–19, along with those risk factors detailed in Semler Scientific’s SEC filings. These forward-looking statements involve assumptions, estimates, and uncertainties that reflect current internal projections, expectations or beliefs. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. All forward-looking statements contained in this press release are qualified in their entirety by these cautionary statements and the risk factors described above. Furthermore, all such statements are made as of the date of this release and Semler Scientific assumes no obligation to update or revise these statements unless otherwise required by law.

INVESTOR CONTACT:

Susan A. Noonan

S.A. Noonan Communications
[email protected]
212 966 3650

Cision View original content:http://www.prnewswire.com/news-releases/semler-reports-first-quarter-2021-financial-results-301282413.html

SOURCE Semler Scientific, Inc.

iRobot Reports First-Quarter 2021 Financial Results

First-Quarter 2021 Revenue Growth of 58% Underpins Stronger-than-Expected Profitability and EPS Performance

PR Newswire

BEDFORD, Mass., May 3, 2021 /PRNewswire/ — iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced its financial results for the first quarter ended April 3, 2021.

Colin Angle, chairman and chief executive officer of iRobot, stated, “Our first-quarter results demonstrate that we are off to a very good start to 2021. Consumer demand for our products has remained resilient and our value proposition to provide customers with a highly differentiated, personalized cleaning experience has continued to resonate around the world. Just as important, we have continued to make tangible progress executing on our strategy as we enhanced our iRobot Genius platform, expanded our connected customer base, introduced a new complementary product and advanced our commercial activities for new services.”

Commenting on the company’s outlook, Angle said, “We have increased our expectations for 2021 revenue to reflect our first-quarter performance and solid growth prospects over the coming quarters. At the same time, we have reaffirmed our 2021 operating income and EPS as we plan to carefully manage our spending to offset higher-than-expected costs arising from the tighter availability of semiconductor chips as well as rising raw material, freight and transportation costs. While it is still early in the year and there is substantial work ahead, we are very excited about our potential to deliver upside to our current targets, assuming demand signals remain favorable and we successfully mitigate the semiconductor chip constraints that are disrupting a wide range of industries. As we execute on our strategy, we remain confident about our ability to capitalize on a wide range of opportunities to sustain our top-line growth and drive meaningful profit and EPS expansion in 2022.”

Financial Performance Highlights

  • Revenue for the first quarter of 2021 was $303.3 million, a 58% increase from $192.5 million in the first quarter of 2020. iRobot’s top-line growth reflected robust expansion in each major geographic region with stronger-than-expected demand from the company’s distribution partners in EMEA and vibrant retail orders in North America, including certain orders that were previously anticipated for the second quarter.
    • iRobot’s revenue grew 40% in the U.S., 74% in EMEA and 53% in Japan compared with the same period last year.
    • We estimate that iRobot’s first-quarter 2021 revenue to support e-commerce, which spans the company’s own website and app, dedicated e-commerce websites and the online arms of traditional retailers, grew by approximately 90% over the first quarter of 2020, and represented approximately 56% of first-quarter 2021 revenue. Direct-to-consumer revenue of $35 million in the first quarter of 2021 grew 146% from the same quarter last year.
    • Product revenue mix was more evenly balanced in the first quarter of 2021 than in recent quarters, which reflected the combination of introducing the i3 Series in major markets outside of the U.S., limited availability of certain premium Roomba robots and lower pricing on certain other product SKUs.
  • GAAP operating income for the first quarter of 2021 was $6.4 million, compared with a GAAP operating loss of $20.2 million in the first quarter of 2020. First-quarter 2021 non-GAAP operating income of $15.0 million compared with a non-GAAP operating loss of $14.4 million in the same period one year ago.
  • GAAP net income per share was $0.26 for the first quarter of 2021, compared with a net loss per share of $0.64 in the first quarter of 2020. Non-GAAP net income per share was $0.41 for the first quarter of 2021 versus a non-GAAP first-quarter 2020 net loss per share of $0.32.
  • As of April 3, 2021, the company’s cash, cash equivalents and short-term investments were $500.8 million, compared with $483.7 million at the end of 2020 and $263.5 million as of March 28, 2020. The company, which has no outstanding debt, also has access to an unsecured revolving line of credit of $150 million, with an additional $75 million accordion feature.

Q121 and Recent Business Highlights

  • iRobot introduced the Roomba i3 and i3+ in EMEA and Japan in January 2021.
  • During the first quarter of 2021, the company delivered an upgraded version of the iRobot Genius Home Intelligence platform, delivering new features and functionality that further personalize the cleaning experience.
  • On April 6, 2021, the company announced the launch of the iRobot H1 handheld vacuum as part of its efforts to address the cleaning needs of Roomba and Braava users, diversify its offerings and grow existing customer revenue through its DTC channel. In addition, iRobot detailed its continued progress with new services including Protect/Protect+ extended warranties, a premium care service and iRobot Select, its robot-as-a-service membership program.
  • On April 8, iRobot disclosed that it entered into a Rule 10b5-1 plan to repurchase $50 million of common stock in the aggregate beginning April 12, 2021 and ending September 5, 2021. All share repurchases made during this period will be done as part of the company’s previously authorized $200 million stock repurchase program.
  • During the first quarter of 2021, iRobot further expanded its community of engaged, connected customers who have opted-in to its digital communications to approximately 10.7 million, a 74% increase over the same period one year ago.
  • Major accolades for iRobot and its products during first quarter of 2021 included Android Central (North America), Better Homes & Gardens (North America), Navi & Kaden Watch (Japan), BBC Science (United Kingdom) and Chip (Germany).
  • In early April 2021, iRobot expanded the set of resources available within iRobot Education that now includes new social-emotional learning resources and multi-language support.

Financial Expectations
iRobot updated its full-year 2021 GAAP and non-GAAP financial expectations for revenue and gross profit and reaffirmed its operating income and EPS expectations, all of which were originally issued on February 10, 2021. A detailed reconciliation between the company’s GAAP and non-GAAP expectations is included in the attached financial tables.


Fiscal Year 2021 ending January 1, 2022:


Metric


GAAP


Adjustments


Non-GAAP

Revenue

$1.67 – $1.71 billion

$1.67 – $1.71 billion

Gross Profit

$642 – $672 million

~$3 million

$645 – $675 million

Operating Income

$69 – $79 million

~$41 million

$110 – $120 million

Earnings Per Share

$1.85 – $2.10

~$1.15

$3.00 – $3.25

First-Quarter 2021 Results Conference Call

iRobot will host a conference call tomorrow at 8:30 a.m. ET to review its first-quarter 2021 financial results, and discuss its outlook going forward. Pertinent conference call details include:

Date:                          

May 4, 2021

Time:                          

8:30 a.m. ET

Call-In Number:         

213-358-0894   

Conference ID:          

1792768

A live webcast of the conference call, along with the conference call prepared remarks, will be accessible on the event section of the company’s website at https://investor.irobot.com/events/event-details/q1-2021-irobot-corp-financial-results-conference-call. An archived version of the broadcast will be available on the same website shortly after the conclusion of the live event. A replay of the telephone conference call will be available through May 11, and can be accessed by dialing 404-537-3406, passcode 1792768.

About iRobot Corp.

iRobot®, the leading global consumer robot company, designs and builds robots that empower people to do more both inside and outside of the home. iRobot created the home robot cleaning category with the introduction of its Roomba® Robot Vacuum in 2002. Today, iRobot is a global enterprise that has sold more than 30 million robots worldwide. iRobot’s product line, including the Roomba and the Braava® family of mopping robots, feature proprietary technologies and advanced concepts in cleaning, mapping and navigation. iRobot engineers are building an ecosystem of robots and technologies to enable the smart home. For more information about iRobot, please visit www.irobot.com.

For iRobot Investors
Certain statements made in this press release that are not based on historical information are forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. This press release contains express or implied forward-looking statements relating to, among other things, iRobot Corp.’s expectations regarding: future financial performance, including with respect to 2021 revenue, gross profit, operating profit and EPS; our plans to carefully manage our spending to offset higher-than-expected costs arising from the tighter availability of semiconductor chips as well as rising raw material, freight and transportation costs; our potential to deliver upside to our current targets, assuming demand signals remain favorable and we successfully mitigate current semiconductor constraints that are disrupting a wide range of industries; and our ability to capitalize on a wide range of opportunities to sustain our top-line growth and drive meaningful profit and EPS expansion in 2022. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things: the impact of COVID-19 on our business, the industry and markets in which we operate, and the global economy; current supply chain challenges including current constraints in the availability of certain semiconductor components used in our products; our ability to operate in an emerging market; the financial strength of our customers and retailers; the impact of tariffs on goods imported into the United States; general economic conditions; market acceptance of and adoption of our products; and competition. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. iRobot Corp. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. For additional disclosure regarding these and other risks faced by iRobot Corp., see the disclosure contained in our public filings with the Securities and Exchange Commission


iRobot Corporation


Consolidated Statements of Operations


(in thousands, except per share amounts)


(unaudited)

For the three months ended

April 3, 2021

March 28, 2020

Revenue

$             303,261

$                   192,535

Cost of revenue:

Cost of product revenue

180,092

114,295

Amortization of acquired intangible assets

225

285

Total cost of revenue

180,317

114,580

Gross profit

122,944

77,955

Operating expenses:

Research and development

41,920

36,759

Selling and marketing

50,990

36,594

General and administrative

23,440

24,573

Amortization of acquired intangible assets

205

254

Total operating expenses

116,555

98,180

Operating income (loss)

6,389

(20,225)

Other expense, net

(160)

(19)

Income (loss) before income taxes

6,229

(20,244)

Income tax benefit

(1,214)

(2,109)

Net income (loss)

$                 7,443

$                   (18,135)

Net income (loss) per share:

Basic

$                   0.26

$                       (0.64)

Diluted

$                   0.26

$                       (0.64)

Number of shares used in per share calculations:

Basic

28,257

28,297

Diluted

29,086

28,297

Stock-based compensation included in above figures:

Cost of revenue

$                    362

$                          527

Research and development

2,149

2,478

Selling and marketing

959

766

General and administrative

3,312

1,420

Total

$                 6,782

$                       5,191

 

 iRobot Corporation


 Condensed Consolidated Balance Sheets


 (unaudited, in thousands)

April 3, 2021

January 2, 2021

 Assets

 Cash and cash equivalents

$                       500,754

$                     432,635

 Short term investments

51,081

 Accounts receivable, net

67,918

170,526

 Inventory

233,113

181,756

 Other current assets

41,369

45,223

Total current assets

843,154

881,221

 Property and equipment, net

80,402

76,584

 Operating lease right-of-use assets

42,086

43,682

 Deferred tax assets

33,408

33,404

 Goodwill

123,273

125,872

 Intangible assets, net

9,312

9,902

 Other assets

26,256

19,063

Total assets

$                    1,157,891

$                  1,189,728

 Liabilities and stockholders’ equity

 Accounts payable

$                       150,769

$                     165,779

 Accrued expenses

105,810

131,388

 Deferred revenue and customer advances

7,294

10,400

Total current liabilities

263,873

307,567

 Operating lease liabilities

48,738

50,485

 Deferred tax liabilities

584

705

 Other long-term liabilities

20,712

26,537

Total long-term liabilities

70,034

77,727

Total liabilities

333,907

385,294

 Stockholders’ equity

823,984

804,434

Total liabilities and stockholders’ equity

$                    1,157,891

$                  1,189,728

 


 iRobot Corporation


Consolidated Statements of Cash Flows


 (unaudited, in thousands)

For the three months ended

April 3, 2021

March 28, 2020


Cash flows from operating activities:

Net income (loss)

$           7,443

$          (18,135)

Adjustments to reconcile net income (loss) to net cash provided by operating
activities:

Depreciation and amortization

7,501

7,459

Stock-based compensation

6,782

5,191

Deferred income taxes, net

(95)

(528)

Other

1,582

1,531

Changes in operating assets and liabilities — (use) source

Accounts receivable

101,459

108,825

Inventory

(51,443)

9,848

Other assets

3,425

(5,612)

Accounts payable 

(15,438)

(41,440)

Accrued expenses and other liabilities

(32,522)

(26,405)

Net cash provided by operating activities

28,694

40,734


Cash flows from investing activities:

Additions of property and equipment

(11,272)

(7,310)

Purchases of investments

(8,664)

(1,560)

Sales and maturities of investments

63,644

3,500

Net cash provided by (used in) investing activities

43,708

(5,370)


Cash flows from financing activities:

Proceeds from employee stock plans

2,589

934

Income tax withholding payment associated with restricted stock vesting

(4,756)

(1,816)

Stock repurchases

(25,000)

Net cash used in financing activities

(2,167)

(25,882)

Effect of exchange rate changes on cash and cash equivalents

(2,116)

(106)

Net increase in cash and cash equivalents

68,119

9,376

Cash and cash equivalents, at beginning of period

432,635

239,392

Cash and cash equivalents, at end of period

$       500,754

$          248,768

 


 iRobot Corporation


Supplemental Information


(unaudited)

For the three months ended

April 3, 2021

March 28, 2020

Revenue by Geography: *

    Domestic

$             114,772

$               81,967

    International

188,489

110,568

Total

$             303,261

$             192,535

Robot Units Shipped *

      Vacuum

971

625

      Mopping

117

96

Total

1,088

721

Revenue by Product Category **

      Vacuum***

$                    270

$                    170

      Mopping***

33

23

Total

$                    303

$                    193

Average gross selling prices for robot units

$                    319

$                    315

Section 301 tariff costs *

$                 3,383

$                 6,609

Section 301 tariff impact on gross and operating margin

(1.1)%

(3.4)%

Headcount

1,267

1,147

* in thousands

** in millions

*** includes accessory revenue


Certain numbers may not total due to rounding

iRobot Corporation

Explanation of Non-GAAP Measures

In addition to disclosing financial results in accordance with U.S. GAAP, this earnings release contains references to the non-GAAP financial measures described below. We use non-GAAP measures to internally evaluate and analyze financial results. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies, many of which present similar non-GAAP financial measures.

Our non-GAAP financial measures reflect adjustments based on the following items. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated.

Amortization of acquired intangible assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.

Net Merger, Acquisition and Divestiture (Income) Expense: Net merger, acquisition and divestiture (income) expense primarily consists of transaction fees, professional fees, and transition and integration costs directly associated with mergers, acquisitions and divestitures. It also includes business combination adjustments including adjustments after the measurement period has ended. The occurrence and amount of these costs will vary depending on the timing and size of these transactions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.

Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards. We exclude this expense as it is a non-cash expense, and we assess our internal operations excluding this expense and believe it facilitates comparisons to the performance of other companies.

IP Litigation Expense, Net: IP litigation expense, net relates to legal costs incurred to litigate patent, trademark, copyright and false advertising infringements, or to oppose or defend against interparty actions related to intellectual property. Any settlement payment or proceeds resulting from these infringements are included or netted against the costs. We exclude these costs from our non-GAAP measures as we do not believe these costs have a direct correlation to the operations of our business and may vary in size depending on the timing and results of such litigations and settlements.

Gain/Loss on Strategic Investments: Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments. We exclude these items from our non-GAAP measures because we do not believe they correlate to the performance of our core business and may vary in size based on market conditions and events. We believe that the exclusion of these gains or losses provides investors with a supplemental view of our operational performance.

Income tax adjustments: Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We reassess the need for any valuation allowance recorded based on the non-GAAP profitability and have eliminated the effect of the valuation allowance recorded in the U.S. jurisdiction. We also exclude certain tax items, including impact from stock-based compensation windfalls/shortfalls, that are not reflective of income tax expense incurred as a result of current period earnings. We believe disclosure of the income tax provision before the effect of such tax items is important to permit investors’ consistent earnings comparison between periods.


iRobot Corporation


Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals


(in thousands, except per share amounts)


(unaudited)

For the three months ended

April 3, 2021

March 28, 2020

 GAAP Revenue

$                   303,261

$               192,535

 GAAP Gross Profit

$                   122,944

$                 77,955

Amortization of acquired intangible assets

225

285

Stock-based compensation

362

527

 Non-GAAP Gross Profit

$                   123,531

$                 78,767

 Non-GAAP Gross Margin

40.7%

40.9%

 GAAP Operating Expenses

$                   116,555

$                 98,180

Amortization of acquired intangible assets

(205)

(254)

Stock-based compensation 

(6,420)

(4,664)

Net merger, acquisition and divestiture income

500

IP litigation expense, net 

(1,140)

(615)

Restructuring and other

(213)

 Non-GAAP Operating Expenses

$                   108,577

$                 93,147

 Non-GAAP Operating Expenses as a % of Non-GAAP Revenue

35.8 %

48.4 %

 GAAP Operating Income (Loss)

$                       6,389

$               (20,225)

Amortization of acquired intangible assets

430

539

Stock-based compensation

6,782

5,191

Net merger, acquisition and divestiture income

(500)

IP litigation expense, net

1,140

615

Restructuring and other

213

 Non-GAAP Operating Income (Loss)

$                     14,954

$               (14,380)

 Non-GAAP Operating Margin

4.9 %

(7.5)%

 GAAP Income Tax Benefit

$                      (1,214)

$                 (2,109)

Tax effect of non-GAAP adjustments

1,398

(1,831)

Other tax adjustments

2,653

(1,384)

 Non-GAAP Income Tax Expense (Benefit)

$                       2,837

$                 (5,324)

 GAAP Net Income (Loss)

$                       7,443

$               (18,135)

Amortization of acquired intangible assets

430

539

Stock-based compensation

6,782

5,191

Net merger, acquisition and divestiture income

(500)

IP litigation expense, net

1,140

615

Restructuring and other

213

Gain on strategic investments

(38)

(87)

Income tax effect

(4,051)

3,215

 Non-GAAP Net Income (Loss)

$                     11,919

$                 (9,162)

 GAAP Net Income (Loss) Per Diluted Share

$                         0.26

$                   (0.64)

Amortization of acquired intangible assets

0.01

0.02

Stock-based compensation

0.23

0.19

Net merger, acquisition and divestiture income

(0.02)

IP litigation expense, net

0.04

0.02

Restructuring and other

0.01

Income tax effect

(0.14)

0.11

 Non-GAAP Net Income (Loss) Per Diluted Share

$                         0.41

$                   (0.32)

Number of shares used in diluted per share calculation

29,086

28,297

Section 301 Tariff Costs

Section 301 tariff costs

$                        3,383

$                    6,609

Impact of Section 301 tariff costs to gross and operating margin (GAAP & non-
GAAP)

(1.1)%

(3.4)%

Impact of Section 301 tariff costs to net income (loss) per diluted share (GAAP
& non-GAAP)

$                         (0.12)

$                    (0.23)

Supplemental Information

Days sales outstanding

20

18

Days in inventory

118

118

 


 iRobot Corporation


Supplemental Reconciliation of Fiscal Year 2021 GAAP to Non-GAAP Guidance


(unaudited)


FY-21

GAAP Gross Profit

$642 – $672 million

Amortization of acquired intangible assets

~$1 million

Stock-based compensation

~$2 million

Total adjustments

~$3 million

Non-GAAP Gross Profit

$645 – $675 million


FY-21

GAAP Operating Income 

$69 – $79 million

Amortization of acquired intangible assets

~$1 million

Stock-based compensation

~$32 million

IP litigation expense, net

~$8 million

Total adjustments

~$41 million

Non-GAAP Operating Income 

$110 – $120 million


FY-21

GAAP Net Income Per Diluted Share

$1.85 – $2.10

Amortization of acquired intangible assets

 ~ $0.03 

Stock-based compensation

 ~ $1.10  

IP litigation expense, net

 ~ $0.27 

Income tax effect

~ ($0.25)

Total adjustments

~ $1.15

Non-GAAP Net Income Per Diluted Share

$3.00 – $3.25

Number of shares used in diluted per share calculations

~ 29.2 million

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/irobot-reports-first-quarter-2021-financial-results-301282453.html

SOURCE iRobot Corporation

Playa Hotels & Resorts N.V. Announces Rescheduled Annual General Meeting of Shareholders

PR Newswire

FAIRFAX, Va., May 3, 2021 /PRNewswire/ — Playa Hotels & Resorts N.V. (NASDAQ: PLYA) (the “Company”) today announced that it has rescheduled its 2021 annual general meeting of shareholders (the “AGM”) to Tuesday, June 29, 2021 at 4:00 p.m. Central European Summer Time (CEST). The rescheduled AGM will be held at the Company’s offices, located at Nieuwezijds Voorburgwal 104, 1012 SG Amsterdam, the Netherlands. At the rescheduled AGM, the Company’s shareholders of record as of June 1, 2021 will vote upon the same proposals described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 19, 2021. Proxies that have been delivered or votes that have been received for the AGM originally scheduled for May 13, 2021 will not be valid. The Company expects to disseminate proxy materials for the rescheduled AGM beginning on or about June 3, 2021. The meeting has been rescheduled in order to comply with a ministerial Dutch law notice requirement.


About Playa Hotels & Resorts N.V.

Playa Hotels & Resorts N.V. is a leading owner, operator and developer of all-inclusive resorts in prime beachfront locations in popular vacation destinations in Mexico and the Caribbean. Playa owns and/or manages a total portfolio consisting of 22 resorts (8,366 rooms) located in Mexico, Jamaica, and the Dominican Republic. Playa leverages years of all-inclusive resort operating expertise and relationships with globally recognized hospitality brands to provide a best in class experience and exceptional value to our guests, while building a direct relationship to improve customer acquisition cost and drive repeat business. Playa owns and manages 17 resorts (6,295 rooms) located throughout Mexico, Jamaica and the Dominican Republic. Playa also owns two resorts in the Dominican Republic that are managed by a third party and manages three resorts on behalf of third-party owners. For more information, please visit www.playaresorts.com

For additional information visit investors.playaresorts.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/playa-hotels–resorts-nv-announces-rescheduled-annual-general-meeting-of-shareholders-301282081.html

SOURCE Playa Hotels & Resorts N.V.

KeyBanc Capital Markets Adds Renewable Energy M&A Team to Expand Its Utilities, Power and Renewables Practice

PR Newswire

CLEVELAND, May 3, 2021 /PRNewswire/ — KeyBanc Capital Markets (KBCM), the corporate and investment banking arm of Cleveland-based KeyCorp (NYSE: KEY), announced today the expansion of its Utilities, Power & Renewables Group through the addition of a six-person renewable energy investment banking team. This team has been a leading provider of strategic, merger and acquisition advisory services to the U.S. renewable energy industry and will further enhance and expand on KBCM’s leading North American project and syndicated finance practice serving the renewable energy industry.

Julian Bailliet, Timothy Beach, Ari Citrin and Oliver Janssen will join KBCM as managing directors, with Mark Dondero joining as a director and Bill Chamberlin joining as a vice president. The team will be based in the firm’s San Francisco office.

“We are committed to expanding our top ranked renewable energy practice,” said Andy Redinger, head of KBCM’s Utilities, Power & Renewable Energy Group. “The addition of this highly successful mergers & acquisition (M&A) team, which will further help broaden our offering and better serve our clients, is an important step towards that commitment.”

KeyBank has been financing renewable power generation in the U.S. since 2007 and is consistently one of the largest U.S bank lenders to the wind and solar industry.  Since 2010, Key has financed more than $15 billion of renewables.  The new team brings extensive renewable energy M&A, capital raising and advisory services experience which will allow Key to continue to provide superior client service to the U.S. power sector.

“Key is uniquely positioned to help lead the transition of the U.S. power system to a more sustainable and competitive position,” said Randy Paine, president of Key Institutional Bank. “The addition of this team is yet another example of Key making strategic investments to drive targeted scale.”


About KeyBanc Capital Markets

KeyBanc Capital Markets is a leading corporate and investment bank providing capital markets and advisory solutions to dynamic companies capitalizing on opportunities in changing industries. Our deep industry expertise, broad capabilities and unique ideas are seamlessly delivered to companies across the Consumer & Retail, Diversified Industries, Healthcare, Industrial, Oil & Gas, Real Estate, Utilities, Power & Renewables, and Technology verticals. With over 800 professionals across a national platform, KeyBanc Capital Markets has more than $37 billion of capital committed to clients and an award-winning Equity Research team that provides coverage on over 600 publicly-traded companies. Securities products and services are offered by KeyBanc Capital Markets Inc. and its licensed securities representatives, who may also be employees of KeyBank N.A. Banking products and services, are offered by KeyBank N.A.


About KeyCorp

KeyCorp’s roots trace back 190 years to Albany, New York. Headquartered in Cleveland, Ohio, Key is one of the nation’s largest bank-based financial services companies, with assets of approximately $176.2 billion at March 31, 2021. Key provides deposit, lending, cash management, and investment services to individuals and businesses in 15 states under the name KeyBank National Association through a network of approximately 1,100 branches and more than 1,400 ATMs. Key also provides a broad range of sophisticated corporate and investment banking products, such as merger and acquisition advice, public and private debt and equity, syndications and derivatives to middle market companies in selected industries throughout the United States under the KeyBanc Capital Markets trade name. For more information, visit https://www.key.com/. KeyBank is Member FDIC.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/keybanc-capital-markets-adds-renewable-energy-ma-team-to-expand-its-utilities-power-and-renewables-practice-301281755.html

SOURCE KeyCorp

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

BOSTON, May 03, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, today announced that on April 30, 2021, the Company granted stock options to seven new employees of the Company. These awards were granted pursuant to the Paratek Pharmaceuticals, Inc. 2017 Inducement Plan, as amended, which was approved by the Company’s board of directors on June 15, 2017, under Rule 5635(c)(4) of the NASDAQ Listing Rules, for equity grants to employees entering into employment or returning to employment after a bona fide period of non-employment with the Company, as an inducement material to such individuals entering into employment with the Company.

The stock options are to acquire, in the aggregate, 14,100 shares of the Company’s common stock at a per share exercise price of $7.65, the closing sales price on April 30, 2021, and shall vest over a four-year vesting period, under which 25% of the shares will vest after 12 months of employment, with the remaining shares vesting monthly thereafter over the remaining 36-month period, subject to the employee’s continuous service. The stock options are subject to the terms and conditions of the Paratek Pharmaceuticals, Inc. 2017 Inducement Plan, as amended, and the terms and conditions of the stock option agreement covering each grant.

About Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use.

The company’s lead commercial product, NUZYRA® (omadacycline), is a once-daily oral and intravenous antibiotic available in the U.S. for the treatment of adults with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Paratek has a collaboration agreement with Zai Lab for the development and commercialization of omadacycline in the greater China region and retains all remaining global rights.

Paratek exclusively licensed U.S. rights and rights to the greater China territory for SEYSARA® (sarecycline), a once-daily oral therapy for the treatment of moderate to severe acne vulgaris, to Almirall, LLC, or Almirall. Paratek retains the development and commercialization rights for sarecycline in the rest of the world.

In 2019, Paratek was awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA) to support the development of NUZYRA for the treatment of pulmonary anthrax.

For more information, visit www.ParatekPharma.com or follow @ParatekPharma on Twitter.

About NUZYRA®
NUZYRA (omadacycline) is a novel antibiotic with both once-daily oral and intravenous formulations for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). A modernized tetracycline, NUZYRA is specifically designed to overcome tetracycline resistance and exhibits activity across a spectrum of bacteria, including Gram-positive, Gram-negative, atypicals, and other drug-resistant strains.

Please see full Prescribing Information for NUZYRA at www.NUZYRA.com.

For more information, visit www.ParatekPharma.com or follow @ParatekPharma on Twitter.

CONTACT:
Investor and Media Relations:     
Ben Strain     
617-807-6688     
[email protected]



Cara Therapeutics to Announce First Quarter 2021 Financial Results on May 10, 2021

STAMFORD, Conn., May 03, 2021 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, today announced that the Company will host a conference call and live audio webcast on Monday, May 10, 2021 at 4:30 p.m. ET to report first quarter 2021 financial results and provide a corporate update.

To participate in the conference call, please dial (855) 445-2816 (domestic) or (484) 756-4300 (international) and refer to conference ID 5789617. A live webcast of the call can be accessed under “Events & Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com.

An archived webcast recording will be available on the Cara website beginning approximately two hours after the call.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs. Cara is developing a novel and proprietary class of product candidates, led by KORSUVA™ (CR845/difelikefalin), a first-in-class KOR agonist that targets the body’s peripheral nervous system, as well as certain immune cells. In two Phase 3 trials, KORSUVA Injection has demonstrated statistically significant reductions in itch intensity and concomitant improvement in quality of life measures in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP). The U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the New Drug Application (NDA) for KORSUVA™ (difelikefalin) solution for injection for the treatment of moderate-to-severe pruritus in hemodialysis patients. The PDUFA target action date for KORSUVA is August 23, 2021. Oral KORSUVA™ has completed Phase 2 trials for the treatment of pruritus in patients with CKD and AD and is currently in Phase 2 trials in primary biliary cholangitis and notalgia paresthetica patients with moderate-to-severe pruritus.

The FDA has conditionally accepted KORSUVA™ as the trade name for difelikefalin injection. CR845/difelikefalin is an investigational drug product and its safety and efficacy have not been fully evaluated by any regulatory authority.

MEDIA CONTACT:

Claire LaCagnina
6 Degrees
315-765-1462
[email protected]

INVESTOR CONTACT:

Janhavi Mohite
Stern Investor Relations, Inc.
212-362-1200
[email protected]